MARKET

LUNG

LUNG

Pulmonx Corp
NASDAQ
9.20
+0.25
+2.79%
After Hours: 9.38 +0.18 +1.96% 17:48 01/27 EST
OPEN
8.76
PREV CLOSE
8.95
HIGH
9.28
LOW
8.76
VOLUME
163.47K
TURNOVER
0
52 WEEK HIGH
29.25
52 WEEK LOW
4.070
MARKET CAP
344.16M
P/E (TTM)
-5.8910
1D
5D
1M
3M
1Y
5Y
Hilltop GAAP EPS of $0.39, revenue of $169.78M
Seeking Alpha · 1d ago
BAND, PRTK and OTLY are among after hour movers
Seeking Alpha · 1d ago
Morgan Stanley Keeps Their Hold Rating on Pulmonx (LUNG)
TipRanks · 01/06 16:27
Morgan Stanley Maintains Equal-Weight on Pulmonx, Lowers Price Target to $9.5
Benzinga · 01/06 15:15
Morgan Stanley Adjusts Price Target on Pulmonx to $9.50 From $14, Maintains Equalweight Rating
Morgan Stanley Adjusts Price Target on Pulmonx to $9.50 From $14, Maintains Equalweight Rating
MT Newswires · 01/06 11:33
Point72 Asset Management shows 5.3% stake in Pulmonx
Seeking Alpha · 01/05 07:09
BRIEF-Steven A. Cohen Reports 5.3 Percent Passive Stake In Pulmonx Corporation As Of Jan 3, 2023 - SEC Filing
Reuters · 01/04 22:20
Analyst Ratings for Pulmonx
Benzinga · 01/03 19:00
More
About LUNG
Pulmonx Corporation is a commercial-stage medical technology company. The Company provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). Its solutions include Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System) and the StratX Lung Analysis Platform (StratX Platform), which is designed to treat severe emphysema patients. Its solutions provide bronchoscopic lung volume reduction without surgery. Zephyr Valves are indicated for bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. The Zephyr Valves are placed in the airways to occlude the diseased parts of the lung, allowing trapped air to escape. The StratX Platform is used to identify patients eligible for treatment with Zephyr Valves. It operates in North America, Europe and Asia Pacific.

Webull offers kinds of Pulmonx Corp stock information, including NASDAQ:LUNG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LUNG stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LUNG stock methods without spending real money on the virtual paper trading platform.